Literature DB >> 22896672

Dietary cholesterol increases paraoxonase 1 enzyme activity.

Daniel S Kim1, Amber A Burt, Jane E Ranchalis, Rebecca J Richter, Julieann K Marshall, Karen S Nakayama, Ella R Jarvik, Jason F Eintracht, Elisabeth A Rosenthal, Clement E Furlong, Gail P Jarvik.   

Abstract

HDL-associated paraoxonase 1 (PON1) activity has been consistently associated with cardiovascular and other diseases. Vitamins C and E intake have previously been positively associated with PON1 in a subset of the Carotid Lesion Epidemiology and Risk (CLEAR) cohort. The goal of this study was to replicate these findings and determine whether other nutrient intake affected PON1 activity. To predict nutrient and mineral intake values, 1,402 subjects completed a standardized food frequency survey of their dietary habits over the past year. Stepwise regression was used to evaluate dietary and covariate effects on PON1 arylesterase activity. Five dietary components, cholesterol (P < 2.0 × 10(-16)), alcohol (P = 8.51 × 10(-8)), vitamin C (P = 7.97 × 10(-5)), iron (P = 0.0026), and folic acid (0.037) were independently predictive of PON1 activity. Dietary cholesterol was positively associated and predicted 5.5% of PON1 activity, second in variance explained. This study presents a novel finding of dietary cholesterol, iron, and folic acid predicting PON1 activity in humans and confirms prior reported associations, including that with vitamin C. Identifying and understanding environmental factors that affect PON1 activity is necessary to understand its role and that of HDL in human disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22896672      PMCID: PMC3466014          DOI: 10.1194/jlr.P030601

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  90 in total

1.  Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.

Authors:  O Stein; Y Dabach; G Hollander; M Ben-Naim; G Halperin; J L Breslow; Y Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes.

Authors:  A J Wallace; W H Sutherland; J I Mann; S M Williams
Journal:  Eur J Clin Nutr       Date:  2001-11       Impact factor: 4.016

3.  Alcohol consumption and risk of lung cancer: the Framingham Study.

Authors:  Luc Djoussé; Joanne F Dorgan; Yuqing Zhang; Arthur Schatzkin; Maggie Hood; Ralph B D'Agostino; Donna L Copenhafer; Bernard E Kreger; R Curtis Ellison
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Elham Bahreini; Nadereh Rashtchizadeh; Hassan Argani; Samira Alizadeh
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

6.  Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis.

Authors:  Mostafa Saadat
Journal:  Cancer Epidemiol       Date:  2011-11-30       Impact factor: 2.984

7.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

8.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

Review 9.  Effect of the dietary fat quality on insulin sensitivity.

Authors:  José E Galgani; Ricardo D Uauy; Carolina A Aguirre; Erik O Díaz
Journal:  Br J Nutr       Date:  2008-04-08       Impact factor: 3.718

10.  Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis.

Authors:  Stephan Riedmaier; Kathrin Klein; Stefan Winter; Ute Hofmann; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2011-07-27       Impact factor: 5.810

View more
  18 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

3.  PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.

Authors:  Daniel Seung Kim; Amber A Burt; Jane E Ranchalis; Simona Vuletic; Tomas Vaisar; Wan-Fen Li; Elisabeth A Rosenthal; Weijiang Dong; Jason F Eintracht; Arno G Motulsky; John D Brunzell; John J Albers; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2015-05-25       Impact factor: 5.922

4.  Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Ella R Jarvik; Elisabeth A Rosenthal; Thomas S Hatsukami; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

5.  Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.

Authors:  Daniel S Kim; Amber A Burt; David R Crosslin; Peggy D Robertson; Jane E Ranchalis; Edward J Boyko; Deborah A Nickerson; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

6.  Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project.

Authors:  Daniel Seung Kim; David R Crosslin; Paul L Auer; Stephanie M Suzuki; Judit Marsillach; Amber A Burt; Adam S Gordon; James F Meschia; Mike A Nalls; Bradford B Worrall; W T Longstreth; Rebecca F Gottesman; Clement E Furlong; Ulrike Peters; Stephen S Rich; Deborah A Nickerson; Gail P Jarvik
Journal:  J Lipid Res       Date:  2014-04-07       Impact factor: 5.922

7.  Association of Paraoxonase-1 Genotype and Phenotype with Angiogram Positive Coronary Artery Disease.

Authors:  Sara Saffar Soflaei; Mojtaba Baktashian; Kiana Hosseinpour Moghaddam; Maryam Saberi-Karimian; Negin Kosari; Seyed Mohammad Hashemi; Mohsen Mouhebati; Mahsa Amini; Mashallah Dehghani; Habibollah Esmaily; Mahmoud Ebrahimi; Homa Falsoleiman; Abolfazl Nosrati-Tirkani; Fatemeh Sadabadi; Gordon A Ferns; Mansoor Salehi; Alireza Pasdar; Majid Ghayour-Mobarhan
Journal:  Arq Bras Cardiol       Date:  2022-09-02       Impact factor: 2.667

8.  Prenatal maternal organophosphorus pesticide exposures, paraoxonase 1, and childhood adiposity in the Mount Sinai Children's Environmental Health Study.

Authors:  Taylor M Etzel; Stephanie M Engel; Lesliam Quirós-Alcalá; Jia Chen; Dana B Barr; Mary S Wolff; Jessie P Buckley
Journal:  Environ Int       Date:  2020-06-26       Impact factor: 9.621

9.  Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults.

Authors:  Andrew J Clifford; Gonzalo Rincon; Janel E Owens; Juan F Medrano; Alanna J Moshfegh; David J Baer; Janet A Novotny
Journal:  Lipids Health Dis       Date:  2013-05-08       Impact factor: 3.876

10.  Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects.

Authors:  Daniel Seung Kim; Sean K Maden; Amber A Burt; Jane E Ranchalis; Clement E Furlong; Gail P Jarvik
Journal:  Lipids Health Dis       Date:  2013-12-12       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.